176 related articles for article (PubMed ID: 16102109)
1. Transplantation of endothelial cells corrects the phenotype in hemophilia A mice.
Kumaran V; Benten D; Follenzi A; Joseph B; Sarkar R; Gupta S
J Thromb Haemost; 2005 Sep; 3(9):2022-31. PubMed ID: 16102109
[TBL] [Abstract][Full Text] [Related]
2. Factor VIII can be synthesized in hemophilia A mice liver by bone marrow progenitor cell-derived hepatocytes and sinusoidal endothelial cells.
Yadav N; Kanjirakkuzhiyil S; Ramakrishnan M; Das TK; Mukhopadhyay A
Stem Cells Dev; 2012 Jan; 21(1):110-20. PubMed ID: 21480781
[TBL] [Abstract][Full Text] [Related]
3. Production of factor VIII by human liver sinusoidal endothelial cells transplanted in immunodeficient uPA mice.
Fomin ME; Zhou Y; Beyer AI; Publicover J; Baron JL; Muench MO
PLoS One; 2013; 8(10):e77255. PubMed ID: 24167566
[TBL] [Abstract][Full Text] [Related]
4. Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A.
Zanolini D; Merlin S; Feola M; Ranaldo G; Amoruso A; Gaidano G; Zaffaroni M; Ferrero A; Brunelleschi S; Valente G; Gupta S; Prat M; Follenzi A
Haematologica; 2015 Jul; 100(7):881-92. PubMed ID: 25911555
[TBL] [Abstract][Full Text] [Related]
5. Expression of factor VIII by murine liver sinusoidal endothelial cells.
Do H; Healey JF; Waller EK; Lollar P
J Biol Chem; 1999 Jul; 274(28):19587-92. PubMed ID: 10391893
[TBL] [Abstract][Full Text] [Related]
6. Donor antigen-primed regulatory T cells permit liver regeneration and phenotype correction in hemophilia A mouse by allogeneic bone marrow stem cells.
Kochat V; Kanjirakkuzhiyil S; Baligar P; Nagarajan P; Mukhopadhyay A
Stem Cell Res Ther; 2015 Jul; 6(1):129. PubMed ID: 26152192
[TBL] [Abstract][Full Text] [Related]
7. The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies.
Shi Q; Schroeder JA; Kuether EL; Montgomery RR
J Thromb Haemost; 2015 Jul; 13(7):1301-9. PubMed ID: 25955153
[TBL] [Abstract][Full Text] [Related]
8. Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice.
Kren BT; Unger GM; Sjeklocha L; Trossen AA; Korman V; Diethelm-Okita BM; Reding MT; Steer CJ
J Clin Invest; 2009 Jul; 119(7):2086-99. PubMed ID: 19509468
[TBL] [Abstract][Full Text] [Related]
9. Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII.
Shahani T; Covens K; Lavend'homme R; Jazouli N; Sokal E; Peerlinck K; Jacquemin M
J Thromb Haemost; 2014 Jan; 12(1):36-42. PubMed ID: 24118899
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic correction of hemophilia A by transplantation of hPSC-derived liver sinusoidal endothelial cell progenitors.
Gage BK; Merlin S; Olgasi C; Follenzi A; Keller GM
Cell Rep; 2022 Apr; 39(1):110621. PubMed ID: 35385743
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing anti-factor VIII immunity.
Kuether EL; Schroeder JA; Fahs SA; Cooley BC; Chen Y; Montgomery RR; Wilcox DA; Shi Q
J Thromb Haemost; 2012 Aug; 10(8):1570-80. PubMed ID: 22632092
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-mediated gene delivery specifically targets liver sinusoidal endothelial cells for sustained FVIII expression in hemophilia A mice.
Lawton SM; Manson MA; Fan MN; Chao TY; Chen CY; Kim P; Campbell C; Cai X; Vander Kooi A; Miao CH
Mol Ther; 2024 Apr; 32(4):969-981. PubMed ID: 38341614
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy.
Xu D; Alipio Z; Fink LM; Adcock DM; Yang J; Ward DC; Ma Y
Proc Natl Acad Sci U S A; 2009 Jan; 106(3):808-13. PubMed ID: 19139414
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic effect of bone marrow-derived liver cells in the phenotypic correction of murine hemophilia A.
Yadav N; Kanjirakkuzhiyil S; Kumar S; Jain M; Halder A; Saxena R; Mukhopadhyay A
Blood; 2009 Nov; 114(20):4552-61. PubMed ID: 19752394
[TBL] [Abstract][Full Text] [Related]
15. Progress and challenges in the development of a cell-based therapy for hemophilia A.
Fomin ME; Togarrati PP; Muench MO
J Thromb Haemost; 2014 Dec; 12(12):1954-65. PubMed ID: 25297648
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors.
Matsui H; Shibata M; Brown B; Labelle A; Hegadorn C; Andrews C; Hebbel RP; Galipeau J; Hough C; Lillicrap D
Stem Cells; 2007 Oct; 25(10):2660-9. PubMed ID: 17615271
[TBL] [Abstract][Full Text] [Related]
17. Role of bone marrow transplantation for correcting hemophilia A in mice.
Follenzi A; Raut S; Merlin S; Sarkar R; Gupta S
Blood; 2012 Jun; 119(23):5532-42. PubMed ID: 22368271
[TBL] [Abstract][Full Text] [Related]
18. Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A.
Olgasi C; Talmon M; Merlin S; Cucci A; Richaud-Patin Y; Ranaldo G; Colangelo D; Di Scipio F; Berta GN; Borsotti C; Valeri F; Faraldi F; Prat M; Messina M; Schinco P; Lombardo A; Raya A; Follenzi A
Stem Cell Reports; 2018 Dec; 11(6):1391-1406. PubMed ID: 30416049
[TBL] [Abstract][Full Text] [Related]
19. A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII.
Fahs SA; Hille MT; Shi Q; Weiler H; Montgomery RR
Blood; 2014 Jun; 123(24):3706-13. PubMed ID: 24705491
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cells derived from patients' induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A.
Rose M; Gao K; Cortez-Toledo E; Agu E; Hyllen AA; Conroy K; Pan G; Nolta JA; Wang A; Zhou P
Stem Cells Transl Med; 2020 Jun; 9(6):686-696. PubMed ID: 32162786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
